Back to results
Completed

Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping

NCT04928976

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Syrentis Clinical Research

Santa Ana, California, United States

View on ClinicalTrials.gov
Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping — TrialFind